The microtubule-affecting drug paclitaxel has antiangiogenic activity. D Belotti, V Vergani, T Drudis, P Borsotti, MR Pitelli, G Viale, R Giavazzi, ... Clinical cancer research: an official journal of the American Association …, 1996 | 826 | 1996 |
Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells G Taraboletti, S D'Ascenzo, P Borsotti, R Giavazzi, A Pavan, V Dolo The American journal of pathology 160 (2), 673-680, 2002 | 756 | 2002 |
Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. G Taraboletti, D Roberts, LA Liotta, R Giavazzi The Journal of cell biology 111 (2), 765-772, 1990 | 535 | 1990 |
Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation D Belotti, P Paganoni, L Manenti, A Garofalo, S Marchini, G Taraboletti, ... Cancer research 63 (17), 5224-5229, 2003 | 476 | 2003 |
Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo D Salani, G Taraboletti, L Rosanò, V Di Castro, P Borsotti, R Giavazzi, ... The American journal of pathology 157 (5), 1703-1711, 2000 | 468 | 2000 |
Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases G Taraboletti, A Garofalo, D Belotti, T Drudis, P Borsotti, E Scanziani, ... JNCI: Journal of the National Cancer Institute 87 (4), 293-298, 1995 | 309 | 1995 |
Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains. G Taraboletti, DD Roberts, LA Liotta The Journal of cell biology 105 (5), 2409-2415, 1987 | 293 | 1987 |
Role of laminin receptor in tumor cell migration UM Wewer, G Taraboletti, ME Sobel, R Albrechtsen, LA Liotta Cancer research 47 (21), 5691-5698, 1987 | 288 | 1987 |
Current understanding of the thrombospondin-1 interactome A Resovi, D Pinessi, G Chiorino, G Taraboletti Matrix Biology 37, 83-91, 2014 | 281 | 2014 |
Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pH G Taraboletti, S D'Ascenzoy, I Giusti, D Marchetti, P Borsotti, D Millimaggi, ... Neoplasia 8 (2), 96-103, 2006 | 260 | 2006 |
Induction of haptotactic migration of melanoma cells by neutrophil activating protein/interleukin-8 JM Wang, G Taraboletti, K Matsushima, J Van Damme, A Mantovani Biochemical and biophysical research communications 169 (1), 165-170, 1990 | 227 | 1990 |
Cathepsin B mediates the pH-dependent proinvasive activity of tumor-shed microvesicles I Giusti, S D’Ascenzo, D Millimaggi, G Taraboletti, G Carta, N Franceschini, ... Neoplasia 10 (5), 481-488, 2008 | 209 | 2008 |
Functional domains of the 67-kDa laminin receptor precursor. V Castronovo, G Taraboletti, ME Sobel Journal of Biological Chemistry 266 (30), 20440-20446, 1991 | 196 | 1991 |
Cytokine-induced pseudopodial protrusion is coupled to tumour cell migration R Guirguis, I Margulies, G Taraboletti, E Schiffmann, L Liotta Nature 329 (6136), 261-263, 1987 | 191 | 1987 |
Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia … M Broggini, SV Marchini, E Galliera, P Borsotti, G Taraboletti, E Erba, ... Leukemia 17 (1), 52-59, 2003 | 189 | 2003 |
The heparin binding 25 kDa fragment of thrombospondin‐1 promotes angiogenesis and modulates gelatinase and TIMP‐2 production in endothelial cells G Taraboletti, L Morbidelli, S Donnini, A Parenti, HJ Granger, R Giavazzi, ... The FASEB Journal 14 (12), 1674-1676, 2000 | 189 | 2000 |
Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with … L Manenti, P Paganoni, I Floriani, F Landoni, V Torri, A Buda, ... European journal of cancer 39 (13), 1948-1956, 2003 | 153 | 2003 |
Vascular-targeting activity of ZD6126, a novel tubulin-binding agent G Micheletti, M Poli, P Borsotti, M Martinelli, B Imberti, G Taraboletti, ... Cancer research 63 (7), 1534-1537, 2003 | 147 | 2003 |
BAY 12-9566, a novel inhibitor of matrix metalloproteinases with antiangiogenic activity C Gatto, M Rieppi, P Borsotti, S Innocenti, R Ceruti, T Drudis, E Scanziani, ... Clinical cancer research 5 (11), 3603-3607, 1999 | 135 | 1999 |
Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune mice. C Zoja, XH Liu, R Donadelli, M Abbate, D Testa, D Corna, G Taraboletti, ... Journal of the American Society of Nephrology 8 (5), 720-729, 1997 | 130 | 1997 |